每日避孕药使新诊断的病人的1型糖尿病发展速度减慢,保持胰岛素生产。 A daily pill slowed type 1 diabetes progression in newly diagnosed patients, preserving insulin production.

一种含有巴里西蒂尼的每日避孕药,一种用于风湿性关节炎等自发性症状的药物,显示有希望减缓最近确诊的病人1型糖尿病的发病速度。 A daily pill containing baricitinib, a drug used for autoimmune conditions like rheumatoid arthritis, showed promise in slowing type 1 diabetes progression in recently diagnosed patients. 对BANDIT试验进行了两年的后续调查,发现它保存了胰岛素生产细胞,稳定了血糖,减少了胰岛素需求,但该药物停用后福利停止了。 A two-year follow-up of the BANDIT trial found it preserved insulin-producing cells, stabilized blood sugar, and reduced insulin needs, but benefits stopped when the drug was discontinued. 研究人员认为,进一步的试验可能导致推迟或防止胰岛素依赖性的治疗,可能在5年内提供。 Researchers believe further trials may lead to a treatment that delays or prevents insulin dependence, with potential availability within five years.